These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 36322543)
1. Serologic Response to Human Papillomavirus Genotypes Among Unvaccinated Women: Findings From the HITCH Cohort Study. Morais S; Wissing MD; Khosrow-Khavar F; Burchell AN; Tellier PP; Coutlée F; Waterboer T; El-Zein M; Franco EL J Infect Dis; 2023 May; 227(10):1173-1184. PubMed ID: 36322543 [TBL] [Abstract][Full Text] [Related]
2. Serologic response to human papillomavirus genotypes following vaccination: findings from the HITCH cohort study. Morais S; Wissing MD; Khosrow-Khavar F; Burchell AN; Tellier PP; Coutlée F; Waterboer T; El-Zein M; Franco EL Infect Dis (Lond); 2024 Jan; 56(1):66-72. PubMed ID: 37994805 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay. Robbins HA; Waterboer T; Porras C; Kemp TJ; Pawlita M; Rodriguez AC; Wacholder S; Gonzalez P; Schiller JT; Lowy DR; Esser M; Matys K; Poncelet S; Herrero R; Hildesheim A; Pinto LA; Safaeian M Hum Vaccin Immunother; 2014; 10(10):2965-74. PubMed ID: 25483632 [TBL] [Abstract][Full Text] [Related]
4. Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus. Robbins HA; Li Y; Porras C; Pawlita M; Ghosh A; Rodriguez AC; Schiffman M; Wacholder S; Kemp TJ; Gonzalez P; Schiller J; Lowy D; Esser M; Matys K; Quint W; van Doorn LJ; Herrero R; Pinto LA; Hildesheim A; Waterboer T; Safaeian M BMC Infect Dis; 2014 Mar; 14():120. PubMed ID: 24588945 [TBL] [Abstract][Full Text] [Related]
5. Empirical sample-specific approaches to define HPV16 and HPV18 seropositivity in unvaccinated, young, sexually active women. Ng K; Morais S; Wissing MD; Burchell AN; Tellier P-P; Coutlée F; Waterboer T; El-Zein M; Franco EL Microbiol Spectr; 2024 Jun; 12(6):e0022924. PubMed ID: 38687066 [TBL] [Abstract][Full Text] [Related]
6. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens. Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304 [No Abstract] [Full Text] [Related]
7. Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes. Godi A; Boampong D; Elegunde B; Panwar K; Fleury M; Li S; Zhao Q; Xia N; Christensen ND; Beddows S J Virol; 2020 Nov; 94(24):. PubMed ID: 32967963 [TBL] [Abstract][Full Text] [Related]
8. Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix® or Gardasil® Vaccine. Godi A; Bissett SL; Miller E; Beddows S PLoS One; 2015; 10(10):e0140926. PubMed ID: 26495976 [TBL] [Abstract][Full Text] [Related]
9. Comparison of a VLP-based and GST-L1-based multiplex immunoassay to detect vaccine-induced HPV-specific antibodies in first-void urine. Pattyn J; Panicker G; Willhauck-Fleckenstein M; Van Keer S; Téblick L; Pieters Z; Tjalma WAA; Matheeussen V; Van Damme P; Waterboer T; Unger ER; Vorsters A J Med Virol; 2020 Dec; 92(12):3774-3783. PubMed ID: 32266996 [TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus (HPV) L1 and L1-L2 virus-like particle-based multiplex assays for measurement of HPV virion antibodies. Hernandez BY; Ton T; Shvetsov YB; Goodman MT; Zhu X Clin Vaccine Immunol; 2012 Sep; 19(9):1348-52. PubMed ID: 22761294 [TBL] [Abstract][Full Text] [Related]
11. Expression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine. Hassan SW; Waheed MT; Müller M; Clarke JL; Shinwari ZK; Lössl AG Hum Vaccin Immunother; 2014; 10(10):2975-82. PubMed ID: 25483463 [TBL] [Abstract][Full Text] [Related]
12. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody. Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF mBio; 2021 Jan; 12(1):. PubMed ID: 33468698 [TBL] [Abstract][Full Text] [Related]
13. Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins. Bissett SL; Mattiuzzo G; Draper E; Godi A; Wilkinson DE; Minor P; Page M; Beddows S Vaccine; 2014 Nov; 32(48):6548-55. PubMed ID: 25203446 [TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus L1 protein expressed in Escherichia coli self-assembles into virus-like particles that are highly immunogenic. Chen Y; Liu Y; Zhang G; Wang A; Dong Z; Qi Y; Wang J; Zhao B; Li N; Jiang M Virus Res; 2016 Jul; 220():97-103. PubMed ID: 27107614 [TBL] [Abstract][Full Text] [Related]
15. Amino acid sequence diversity of the major human papillomavirus capsid protein: implications for current and next generation vaccines. Ahmed AI; Bissett SL; Beddows S Infect Genet Evol; 2013 Aug; 18():151-9. PubMed ID: 23722024 [TBL] [Abstract][Full Text] [Related]
16. Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity. Karanam B; Gambhira R; Peng S; Jagu S; Kim DJ; Ketner GW; Stern PL; Adams RJ; Roden RB Vaccine; 2009 Feb; 27(7):1040-9. PubMed ID: 19095032 [TBL] [Abstract][Full Text] [Related]
17. Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status. Singini MG; Muchengeti M; Sitas F; Chen WC; Combes JD; Waterboer T; Clifford GM Int J Cancer; 2024 Jul; 155(2):251-260. PubMed ID: 38577820 [TBL] [Abstract][Full Text] [Related]
18. Genetic Variability in the E6, E7, and L1 Genes of Human Papillomavirus Types 16 and 18 among Women in Saudi Arabia. Alsanea M; Alsaleh A; Obeid D; Alhadeq F; Alahideb B; Alhamlan F Viruses; 2022 Dec; 15(1):. PubMed ID: 36680149 [TBL] [Abstract][Full Text] [Related]
19. Developments in L2-based human papillomavirus (HPV) vaccines. Schellenbacher C; Roden RBS; Kirnbauer R Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616 [TBL] [Abstract][Full Text] [Related]
20. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. Sehr P; Müller M; Höpfl R; Widschwendter A; Pawlita M J Virol Methods; 2002 Oct; 106(1):61-70. PubMed ID: 12367730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]